author-photo

Ekaterini Boleti

Royal Free Hospital

22

Papers

1629

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Surgical safety of Cytoreductive Nephrectomy (CN) following pretreatment with Immune Checkpoint Inhibition (ICI) combination therapy in primary metastatic clear-cell Renal Carcinoma (mccRCC)

2021 European Urology
Show All
- Source
- Cite
- Save
Citations (0)
737P Synchronous metastatic renal cell carcinoma (mRCC) treated with nivolumab and ipilimumab (N+I) and the primary tumour (PT) in place

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Axitinib in advanced renal cell carcinoma: real-life data and dose modification audit

2019 Clinical Medicine
- Rosemeen Parkar
- Ekaterini Boleti
Show All
- Source
- Cite
- Save
Citations (0)
135PAxitinib: An audit of dose adjustments, tolerability and efficacy in advanced renal cell carcinoma

2018 Annals of Oncology
- R Parkar
- Ekaterini Boleti
Show All
- Source
- Cite
- Save
Citations (0)
PNFLBA-16 FIRST RESULTS OF A-PREDICT: A PHASE II STUDY OF AXITINIB IN PATIENTS WITH METASTATIC RENAL CELL CANCER (RCC) UNSUITABLE FOR NEPHRECTOMY

2017 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (0)
Outcome of rapid disease progression in the treatment break following cytoreductive nephrectomy (CN) after presurgical sunitinib in patients with primary metastatic renal cell carcinoma (RCC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Pazopanib prior to planned nephrectomy in metastatic clear cell renal cancer: A clinical and biomarker study.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer

2016 European Urology
Show All
- Source
- Cite
- Save
Citations (64)
Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer

2016 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (51)
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus

2015 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (34)